Praxis Precision Medicines, Inc.
PRAXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $7.54B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $154.45$392.70
- Volume (live)
- -
- Avg. volume (3M)
- 544.14K
Praxis Precision Medicines (PRAX) Stock Price & Financial Analysis
Praxis Precision Medicines Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $253.05 - $263.82 |
|---|---|
| 52-Week High | $392.70 |
| 52-Week Low | $154.45 |
| Open | $253.05 |
| Volume (last close) | 355.67K |
| Average Volume (3M) | 544.14K |
| 50-Day MA | $317.81 |
|---|---|
| 200-Day MA | $315.42 |
| 1-Year Change | +45.45% |
| Market Cap | 7.54B |
|---|---|
| Shares Outstanding | 29.13M |
| Price to Book (P/B) | 5.62 |
| EV/EBITDA | -20.58 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Praxis Precision Medicines at a Glance
As of the Oct 22, 2026 close, Praxis Precision Medicines (PRAX) has a market capitalization of $7.54B. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $474.76M in cash and securities against $1.09M of debt, a net cash position of $473.67M.
Praxis Precision Medicines does not currently pay a dividend.
The share price is up 45.5% over the past year. At $258.92 (the Oct 22, 2026 close) it sits within its 52-week range of $154.45 to $392.70, below its 200-day moving average of $315.42.
Based on 18 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $702.18, 171.2% above the Oct 22, 2026 close.
Frequently Asked Questions About Praxis Precision Medicines
What is the current stock price for PRAX?
As of the Oct 22, 2026 close, PRAX stock trades at $258.92. The 52-week range is $154.45–$392.70, with a day range of $253.05–$263.82.
What is the P/E ratio for PRAX?
The P/E ratio (Price-to-Earnings) for PRAX is shown in the Key Statistics section. This valuation metric helps compare Praxis Precision Medicines, Inc. to industry peers.
Does PRAX pay dividends?
Praxis Precision Medicines does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRAX?
Based on ratings from 18 professional analysts over the last 90 days, the consensus for PRAX is Buy. The average 12-month price target is $702.18, a 171.2% upside from the Oct 22, 2026 close of $258.92.
What is the market cap of PRAX?
As of the Oct 22, 2026 close, Praxis Precision Medicines's market capitalization is $7.54B, classifying it as a mid-cap company. Praxis Precision Medicines operates in the Healthcare sector within the Biotechnology industry.